Worldquant Millennium Advisors LLC increased its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 45.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 450,775 shares of the company's stock after purchasing an additional 140,594 shares during the period. Worldquant Millennium Advisors LLC's holdings in Procter & Gamble were worth $75,572,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC raised its position in shares of Procter & Gamble by 933.3% during the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after acquiring an additional 140 shares during the last quarter. Navigoe LLC bought a new stake in shares of Procter & Gamble during the 4th quarter valued at $31,000. Hoey Investments Inc. raised its position in shares of Procter & Gamble by 321.7% during the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new stake in shares of Procter & Gamble during the 4th quarter valued at $34,000. Finally, Atlantic Private Wealth LLC raised its position in shares of Procter & Gamble by 95.3% during the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock valued at $35,000 after acquiring an additional 101 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $164.78 on Tuesday. The firm has a market cap of $386.33 billion, a PE ratio of 26.24, a PEG ratio of 3.76 and a beta of 0.41. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1-year low of $156.58 and a 1-year high of $180.43. The company has a fifty day moving average price of $164.42 and a 200 day moving average price of $167.31.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. During the same period in the previous year, the firm posted $1.52 EPS. The company's revenue for the quarter was down 2.1% on a year-over-year basis. Research analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Monday, April 21st. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a yield of 2.57%. Procter & Gamble's payout ratio is 66.98%.
Wall Street Analyst Weigh In
Several analysts have commented on the stock. Piper Sandler upped their target price on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. Redburn Partners set a $161.00 target price on shares of Procter & Gamble in a research report on Thursday, May 1st. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Truist Financial decreased their price target on shares of Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a report on Friday, April 25th. Finally, Bank of America decreased their price target on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a report on Friday, April 25th. Eight analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $178.52.
Check Out Our Latest Report on Procter & Gamble
Insiders Place Their Bets
In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the sale, the insider now directly owns 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the completion of the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at approximately $3,829,817.68. The trade was a 61.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 64,520 shares of company stock valued at $10,999,268 in the last three months. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.